Journée médicale #11 ¦ Ostéoporose - Pr Emmanuel Biver

This conference provides an overview of osteoporosis management in 2026. Through concrete clinical cases and a review of the latest data, this session addresses fracture risk assessment, therapeutic indications, available treatments, and their monitoring. The program includes: fragility fractures, Swiss epidemiology, the treatment gap, FRAX use, imminent fracture risk, very high-risk patients, antiresorptive and anabolic therapies, treatment sequences, biological and densitometric monitoring, as well as the management of adverse effects and misconceptions surrounding osteoporosis treatments. Chapters: 00:00 Introduction: Osteoporosis, a common and underdiagnosed disease 01:13 Clinical case: From wrist fracture to fracture cascade 02:25 The treatment gap in Switzerland and public health challenges 04:18 Major osteoporotic fractures: Definition and clinical consequences 05:50 Assessing fracture risk: Limitations and use of FRAX 07:13 Imminent risk and very high risk: Which patients should be treated quickly? 10:38 General measures: calcium, vitamin D, protein, and fall prevention 12:46 Osteoporosis treatments: bone resorption inhibitors and anabolic agents 16:44 Treatment strategies, treatment sequences, and monitoring 22:49 Side effects, misconceptions, and key messages for practice #Osteoporosis #FragilityFracture #BoneHealth #FamilyMedicine #BoneDensity #FRAX #Bisphosphonates #FracturePrevention #Rheumatology #Geriatrics #MedicalTraining